期刊
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY
卷 223, 期 -, 页码 115-123出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cbpc.2019.05.008
关键词
Reserpine; Dopaminergic system; Zebrafish larvae
资金
- National Natural Science Foundation of China [81673643, 31501146, 31471269]
- Science and Technology Department of Zhejiang Province [2012C23066, LQ15C120001]
- Student Science and Technology Innovation Activity Plan of Zhejiang Province [2018R413030, 2018R413185]
- Wenzhou Municipal Science and Technology Bureau Program [Y20170017, Y20160195]
- Wenzhou Medical and Health Research Project [2018A09, 2018A10]
- Key Research Project of Zhejiang Province [2015C03040]
- Zhejiang Province Science & Technology (Laboratory Animal) Project [2017C37127]
Reserpine is widely used for treatment of hypertension and schizophrenia. As a specific inhibitor of monoamine transporters, reserpine is known to deplete monoamine neurotransmitters and cause decreased movement symptoms. However, how zebrafish larvae respond to reserpine treatment is not well studied. Here we show that swimming distance and average velocity are significantly reduced after reserpine exposure under various stimulatory conditions. Using liquid chromatograph mass spectrometer analysis, decreased levels of monoamines (e.g. dopamine, noradrenaline, and serotonin) were detected in reserpine-treated larvae. Moreover, reserpine treatment significantly reduced the number of dopaminergic neurons, which was identified with th (Tyrosine Hydroxylase) in situ hybridization in the preoptic area. Interestingly, dopaminergic neuron development-associated genes, such as otpa, otpb, wnt1, wnt3, wnt5 and manf; were downregulated in reserpine treated larvae. Our data indicates that 2 mg/L reserpine exposure induces dopaminergic neuron damage in the brain, demonstrating a chemical induced depression-like model in zebrafish larvae for future drug development.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据